Pharmaceutical Executive, August 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive August 2021 issue in an interactive PDF format.
Articles in this issue
Why the Pandemic is Rewriting the Biopharma Rule Book
Primary Care in Crisis: PCP Navigation in a Specialty World
A Brave New World: Optimizing Access in Wake of COVID
By Any Genes Necessary: The Role of MEAs for Gene Therapies
A Framework for Future: Strengthening Market Access Competencies
Value Risk and Reward: Taking Stock of Value-Based Contracts in Pharma
Capitalizing on Collaboration: The Effort to Sustain Pandemic-Partnering Momentum
A Global Vision for Access
Early Payer-Related Lessons for Pharma Post-Aduhelm Approval
Biotech Capital Markets Continue to Underperform
Managing the People Side of AI Adoption
Pandemic Heightens Concern Over Workplace Burnout
Contention Swirls Around COVID Patent Waivers
Drug Prices Targeted in Biden Executive Order
Pharm Exec at 40 (2003-2006)
Recent Videos
Related Content
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Podcast
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
